SCHEMBL25460883

SCHEMBL25460883

CNC(=O)C(C)(C)c1cc(F)cc(OC)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKR1C3 P42330 1/20 0.39
▸ AKR1C2 P52895 1/20 0.39
▸ ALOX5 P09917 2/20 0.36
▸ GAA P10253 2/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ SCN9A Q15858 1/20 0.34
▸ PLK1 P53350 1/20 0.34
▸ PDK1 Q15118 2/20 0.34
▸ PDK2 Q15119 2/20 0.34
▸ PDK3 Q15120 2/20 0.34
▸ PDK4 Q16654 2/20 0.34
▸ ADCY8 P40145 1/20 0.33
▸ ADCY1 Q08828 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ CACNA1H O95180 1/20 0.33
▸ CTSD P07339 1/20 0.33
▸ BACE1 P56817 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25460886 0.85 TRPV1 (0.36) ALOX5SCN9A
SCHEMBL25460811 0.85 SLC6A3 (0.40) GAAALDH1A1NPC1RAB9AMAPT
SCHEMBL25173436 0.84 AKR1C3 (0.40) AKR1C3AKR1C2ALOX5GAAALDH1A1
SCHEMBL25168983 0.82 AKR1C3 (0.55) AKR1C3AKR1C2ALOX5ALDH1A1
SCHEMBL25464785 0.81 MEN1 (0.42) ALDH1A1KDM4EMAPTCACNA1H
SCHEMBL25460807 0.80 CNR2 (0.35) ALDH1A1NPC1RAB9AMAPT
SCHEMBL25460884 0.79 MAPT (0.49) ALDH1A1SCN9AMAPT
SCHEMBL25460880 0.79 CA12 (0.40) GAAALDH1A1NPC1RAB9AMAPT
SCHEMBL25460876 0.78 HDAC3 (0.34) MAPT
SCHEMBL25460833 0.76 NPC1 (0.47) PLK1PDK1PDK2PDK3PDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230151074-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS CARMOT THERAPEUTICS, INC. 2023-05-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230151074-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS GIPR, GLP1R, GCGR AKR1C3 3106/4885AKR1C2 2812/4885ALOX5 4324/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback